2-(4-Methoxy-3-nitrobenzylsulfonyl)acetic acid, 98%, 1g

3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole, 95.0%, 10g

6-Chloropyrido[3,2-b]pyrazine, 95.0%, 1g

2-oxo-1,2-dihydroquinoline-8-carboxylic acid, 98%, 1g

2-Methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-amine, 97%, 100mg

Ethylbenzene, min 99%, for synthesis, 2.5 L, glass packaging

N-Propylsulfamide, 95.0%, 1g

2,5-Dichloro-4,6-dimethylpyrimidine, 95.0%, 100mg

5-amino-2-[(tetrahydro-2-furanylmethyl)amino]benzoic acid, 95.0%, 5g

Moexipril hydrochloride, 98%, 100mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 100mg

Three-necked round-bottom flasks side necks, bevelled, 50 ml, 14/23, 14/23, 1 Piece

Methyl 3-chloro-2-fluoro-5-(trifluoromethyl)benzoate, 97%, 10g